Form 4: Teleflex Director Andrew Krakauer Receives Equity Grant

Director Andrew Krakauer was granted 1,090 restricted stock units and 2,397 stock options as part of the 2023 Stock Incentive Plan.

Summary

• Director Andrew Krakauer acquired 1,090 restricted stock units (RSUs) on May 15, 2026.
• The director also received a grant of 2,397 stock options with an exercise price of $129.71.
• Following these transactions, the director's total beneficial ownership of common stock increased to 8,308.5344 shares.
• Both the RSU and option awards are subject to a one-year vesting schedule, with specific provisions related to the 2027 annual meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which carries no significant signal regarding company performance.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.
• Standardized incentive structure under the 2023 Stock Incentive Plan.

Negatives

• Dilutive impact of new equity grants on existing shareholders, though minor in scale.

Risks

• Vesting conditions are contingent upon the director's continued service or specific re-election criteria for the 2027 annual meeting.

Future Outlook

The awards vest on the one-year anniversary of the grant date, subject to the director's status regarding the 2027 annual meeting of stockholders.

Management Comments

• The grants were issued pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices designed to ensure directors maintain a vested interest in the company's long-term performance, consistent with peers in the medical device sector.

Comparison to Industry Standards

• The use of RSU and option grants for non-employee directors is consistent with compensation practices at large-cap medical technology firms like Medtronic or Becton Dickinson.
• Vesting periods of one year are standard for annual director equity retainers.

Corporate Governance

Stakeholder Impact

• Minor dilution for existing shareholders due to the issuance of new equity awards.

Next Steps

• Vesting of RSU and option awards on May 15, 2027.

Key Dates

Keywords

Teleflex, TFX, Form 4, Insider Trading, Equity Compensation, Director Compensation